FI884984A - Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi - Google Patents

Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI884984A
FI884984A FI884984A FI884984A FI884984A FI 884984 A FI884984 A FI 884984A FI 884984 A FI884984 A FI 884984A FI 884984 A FI884984 A FI 884984A FI 884984 A FI884984 A FI 884984A
Authority
FI
Finland
Prior art keywords
tritio
methyl
compounds
preparing target
target derivatives
Prior art date
Application number
FI884984A
Other languages
English (en)
Swedish (sv)
Other versions
FI95204B (fi
FI95204C (fi
FI884984A0 (fi
Inventor
William James Mcgahren
Martin Leon Sassiver
George A Ellestad
Philip R Hamann
Lois M Hinman
Janis Upeslacis
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI884984A0 publication Critical patent/FI884984A0/fi
Publication of FI884984A publication Critical patent/FI884984A/fi
Publication of FI95204B publication Critical patent/FI95204B/fi
Application granted granted Critical
Publication of FI95204C publication Critical patent/FI95204C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI884984A 1987-10-30 1988-10-28 Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi FI95204C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30
US11494087 1987-10-30

Publications (4)

Publication Number Publication Date
FI884984A0 FI884984A0 (fi) 1988-10-28
FI884984A true FI884984A (fi) 1989-05-01
FI95204B FI95204B (fi) 1995-09-29
FI95204C FI95204C (fi) 1996-01-10

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
FI884984A FI95204C (fi) 1987-10-30 1988-10-28 Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi
FI884983A FI91262C (fi) 1987-10-30 1988-10-28 Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI884983A FI91262C (fi) 1987-10-30 1988-10-28 Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi

Country Status (19)

Country Link
EP (2) EP0313873B1 (fi)
JP (2) JP2820256B2 (fi)
KR (2) KR970011385B1 (fi)
AR (1) AR246083A1 (fi)
AT (2) ATE104309T1 (fi)
AU (2) AU612714B2 (fi)
BR (1) BR1100939A (fi)
CA (1) CA1321582C (fi)
DE (2) DE3851682T2 (fi)
DK (2) DK174739B1 (fi)
ES (2) ES2061586T3 (fi)
FI (2) FI95204C (fi)
HK (2) HK131897A (fi)
IE (2) IE65053B1 (fi)
IL (2) IL87947A (fi)
NO (2) NO173506C (fi)
NZ (2) NZ226727A (fi)
PT (2) PT88882B (fi)
ZA (2) ZA888127B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
DK1721979T3 (da) 1998-11-27 2010-12-13 Ucb Pharma Sa Sammensætninger og fremgangsmåder til forøgelse af knoglemineralisering
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
NO345763B1 (no) 2003-06-16 2021-07-19 Celltech R&D Inc Immunogen og antistoffer spesifikke for sklerostin, samt farmasøytiske preparater for å øke benmineralisering.
US8841092B2 (en) * 2006-08-30 2014-09-23 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
HUE047665T2 (hu) * 2013-11-04 2020-05-28 Pfizer Köztitermékek és eljárások kalikeamicin-származékok elõállításához
CA3051038C (en) * 2017-01-24 2022-07-26 Pfizer Inc. Calicheamicin derivatives and antibody drug conjugates thereof
SG11202108655TA (en) * 2019-02-15 2021-09-29 Univ Southern California Lym-1 and lym-2 antibody compositions and improved car constructs
JPWO2022085762A1 (fi) * 2020-10-22 2022-04-28

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
DE3175151D1 (en) * 1980-05-21 1986-09-25 Teijin Ltd Reactive polymer and process for the preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
EP0182152B1 (en) * 1984-11-16 1999-05-26 American Cyanamid Company Antitumor antibiotics (LL-E33288 Complex)
EP0330874A3 (en) * 1988-02-29 1989-10-18 American Cyanamid Company Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2

Also Published As

Publication number Publication date
HK131997A (en) 1997-10-03
JP2720933B2 (ja) 1998-03-04
KR970011385B1 (ko) 1997-07-10
AU618763B2 (en) 1992-01-09
EP0313873A1 (en) 1989-05-03
FI95204B (fi) 1995-09-29
DK174739B1 (da) 2003-10-13
KR0133130B1 (ko) 1998-04-17
HK131897A (en) 1997-10-03
FI95204C (fi) 1996-01-10
DE3889063T2 (de) 1994-12-01
NZ226727A (en) 1991-12-23
IE65989B1 (en) 1995-11-29
DK602488D0 (da) 1988-10-28
AU2449488A (en) 1989-05-04
IL87946A0 (en) 1989-03-31
FI884983A (fi) 1989-05-01
FI884983A0 (fi) 1988-10-28
NO884833D0 (no) 1988-10-28
PT88882B (pt) 1993-01-29
CA1321582C (en) 1993-08-24
IE65053B1 (en) 1995-10-04
IL87947A (en) 1995-05-26
FI884984A0 (fi) 1988-10-28
NO173506C (no) 1993-12-22
JPH01193282A (ja) 1989-08-03
NO173506B (no) 1993-09-13
ES2061586T3 (es) 1994-12-16
NO884834D0 (no) 1988-10-28
BR1100939A (pt) 1999-08-31
EP0313874A2 (en) 1989-05-03
JP2820256B2 (ja) 1998-11-05
FI91262C (fi) 1994-06-10
AU2448988A (en) 1989-05-04
NO176480C (no) 1995-04-12
EP0313874B1 (en) 1994-04-13
IE883262L (en) 1989-04-30
IL87946A (en) 1995-06-29
AU612714B2 (en) 1991-07-18
JPH0296599A (ja) 1990-04-09
NO884833L (no) 1989-05-02
ATE112172T1 (de) 1994-10-15
FI91262B (fi) 1994-02-28
PT88881B (pt) 1993-01-29
ZA888123B (en) 1989-07-26
ES2059464T3 (es) 1994-11-16
DE3851682T2 (de) 1995-05-04
IL87947A0 (en) 1989-03-31
DK602588D0 (da) 1988-10-28
EP0313874A3 (en) 1990-05-09
KR890006244A (ko) 1989-06-12
NZ226726A (en) 1991-08-27
DE3889063D1 (de) 1994-05-19
IE883261L (en) 1989-04-30
KR890006245A (ko) 1989-06-12
AR246083A1 (es) 1994-03-30
DK602488A (da) 1989-05-01
ZA888127B (en) 1989-07-26
EP0313873B1 (en) 1994-09-28
NO176480B (no) 1995-01-02
NO884834L (no) 1989-05-02
ATE104309T1 (de) 1994-04-15
DK602588A (da) 1989-05-01
DE3851682D1 (de) 1994-11-03

Similar Documents

Publication Publication Date Title
FI883064A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI880941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI880757A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tyydytettyjä heterosyklisiä karboksamidijohdoksia
FI884984A (fi) Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI892182A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI97230B (fi) Menetelmä terapeuttisesti käyttökelpoisten 7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinijohdannaisten valmistamiseksi
FI90430C (fi) Menetelmä 2-substituoitujen adenosiinijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI98812B (fi) Menetelmä tulehduksenvastaisten tai analgeettisten -aminoetyylisubstituoitujen fenyyliyhdisteiden valmistamiseksi
FI104171B1 (fi) Menetelmä mono-N-alkyloitujen polyatsamakrosyklisten yhdisteiden valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903863A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI92065C (fi) Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI880716A (fi) Menetelmä terapeuttisesti käyttökelpoisten aryylipiperatsinyylialkyleenifenyylisubstituoitujen heterosyklisten yhdisteiden valmistamiseksi
FI891144A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten suolayhdisteiden valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI901606A0 (fi) Tieno-triatsolo-diatsepiinien sulfonyylijohdosten valmistusmenetelmä

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WYETH HOLDINGS CORPORATION

MA Patent expired